Back Portfolio Strategy

Heightened Recession Fears Likely Over the Summer + Interest Rate Trades

Published on June 27, 2025

∙ Download the PDF Report

By

Dennis DeBusschere

Brian Herlihy

Kevin Brocks

Sophia Wang

SUMMARY: The investor survey we conducted last week showed a rolling over of labor markets as one of the biggest investor concerns (HERE). Claims data were fine yesterday, but we are still getting questions about labor market weakness this summer.

As Peter Williams laid out HERE, tariffs are imposing modest hits to productivity growth and investment, and immigration’s rapid decline is slowing trend labor supply growth. GDP growth should slow over the summer, and the labor market slack will increase some. Investors will be concerned about pre-recessionary economic conditions. That SHOULD keep 10yr yields anchored and financial conditions easy.

The process of economic and payroll growth slowing COULD be a tailwind for Homebuilders over the coming months. A group that many investors are negative on (we agree with the negative long-term homebuilder call). Biotech also looks interesting on the long side. Biotech has unusually high short interest now. With the help of Jeff Jacobson, 22V options strategist, we introduce two options trades today to take advantage of upside risk in Homebuilders and Biotech through the summer.

Longer Term – The lack of accelerating weakness in the labor market and continued health in aggregate balance sheets, credit markets, and the private sector financial balance should help put a floor under growth and recessionary fears. On Tuesday (HERE), we outlined how an increase in yields can happen in late summer as labor markets and demand growth stabilize, and a fiscal impulse in the 1H26 is discounted. With inflation still likely to be above the Fed’s 2% target at the same time, 10yr yields WILL have significant upside risk. That will be a major headwind for interest rate-sensitive sectors like Homebuilders and Biotech. But we can’t ignore what looks like a pretty benign short-term backdrop for rate vol near term.

More details in the full report below…

MARKET VIEWS: The 22V call is that tariffs are imposing modest hits to productivity growth and investment, and immigration’s rapid decline is slowing trend labor supply growth (HERE). These jointly are imparting a downward blip to GDP growth that is NOT expected to lead to a non-linear recessionary weakening of the economy. Some labor market slack is going to increase over the coming months though. It is fair to assume that as GDP growth slows and the labor market slack opens some, investors will be concerned about pre-recessionary economic conditions.

INTEREST RATE SENSITIVE TRADES: The lack of accelerating weakness in the labor market and continued health in aggregate balance sheets, credit markets, and the private sector financial balance should help put a floor under growth and recessionary fears. On Tuesday (HERE), we framed out how an increase in yields can happen in late summer as it becomes apparent that we have a tighter-than-expected labor market, stronger-than-expected demand growth, and a fiscal impulse in the first half of 2026*. In the meantime, yields are likely to be anchored and financial conditions easy. That COULD be a tailwind to Homebuilders over the coming months. A group that many investors are negative on (we agree with the negative long term homebuilder call).

*None of the developments in the fiscal picture yesterday were surprises. This point remains in place. Our broader view on yields depends more on our labor market and demand growth views though.

The same logic applies to Biotech. There’s an overhang from government policy, but the group is still trading with high sensitivity to yields…

…while Biotech short interest is at an all-time high.

Jeff Jacobson, 22V Derivatives specialist, structured short-term ITB and XBI options trades, expiring in August, to position for our view.

ITB: Jeff would target a breakout above the YTD downtrend as well as the 100-day moving average.

2-month (Aug) implied vol has come down substantially, and with sentiment (and likely) positioning negative, buying calls outright makes the most sense.

Trade:

Buy ITB Aug 95 calls for ~ $2.70 (ITB 92 ref)

> Buying the August 42-delta upside calls

> Implied vol down to ~ 26-27 from a high ~ 44 in April

> The 95 strike call is just above both the YTD downtrend as well as the 100-day moving average

> Aug expiry captures earnings from many of the main builders (DHI, PHM, NVR)

XBI: Similar to ITB, Jeff wants to own calls outright in XBI if looking to play upside:

1) 2-month 40-delta call vol is back near the lows

2) Sentiment remains very bearish and perhaps most importantly, short-interest is now at 5-year highs

Trade:

Buy XBI Aug 87 calls for ~ $1.95 (XBI 83.55 ref)

> Buying the Aug 37-delta calls

> Seeing 2-month 40-delta call vol down from 47 to a current 26

> With short-interest at these levels any good news for the sector could really get things moving quickly

DISCLOSURES AND DISCLAIMERS

Analyst Certification

The analyst, 22V Research Group, primarily responsible for the preparation of this research report attests to the following: (1) that the views and opinions rendered in this research report reflect his or her personal views about the subject companies or issuers; and (2) that no part of the research analyst’s compensation was, is, or will be directly related to the specific recommendations or views in this research report.

Analyst Certifications and Independence of Research.

Each of the 22V Research analysts whose names appear on the front page of this report hereby certify that all the views expressed in this Report accurately reflect our personal views about any and all of the subject securities or issuers and that no part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views of in this Report.

22V Research (the “Company”) is an independent research provider. The Company is not a member of the FINRA or the SIPC and is not a registered broker dealer or investment adviser. 22V Research has no other regulated or unregulated business activities which conflict with its provision of independent research.

22V Research, LLC is a professional services and independent publication organization. 22V Research, LLC is not a securities broker-dealer, not a member of the Financial Industry Regulatory Authority (FINRA), not a registered investment advisor (RIA) and not a member of SIPC.

Securities transactions, when offered, are offered by 22V Securities, LLC through LPS Capital, LLC. Certain employees of 22V Securities, LLC are dually registered as securities representatives of LPS Capital, LLC or Analyst Hub Securities, LLC. 22V Securities, LPS Capital and Analyst Hub Securities are members FINRA, SIPC.

https://brokercheck.finra.org/

Current Ratings Definition.

SECTOR OUTPERFORM: An “outperform” rating anticipates the company will outperform the S&P Regional Banking Index (peer group).

SECTOR PERFORM: A “market perform” rating anticipates the company will perform in line with the S&P Regional Banking Index (peer group).

SECTOR UNDERPERFORM: An “underperform” rating anticipates the company will underperform the S&P Regional Banking Index (peer group).

Limitation Of Research And Information.

This Report has been prepared for distribution to only qualified institutional or professional clients of 22V Research Group. The contents of this Report represent the views, opinions, and analyses of its authors. The information contained herein does not constitute financial, legal, tax or any other advice. All third-party data presented herein were obtained from publicly available sources which are believed to be reliable; however, the Company makes no warranty, express or implied, concerning the accuracy or completeness of such information. In no event shall the Company be responsible or liable for the correctness of, or update to, any such material or for any damage or lost opportunities resulting from use of this data. Nothing contained in this Report or any distribution by the Company should be construed as any offer to sell, or any solicitation of an offer to buy, any security or investment. Any research or other material received should not be construed as individualized investment advice. Investment decisions should be made as part of an overall portfolio strategy and you should consult with a professional financial advisor, legal and tax advisor prior to making any investment decision. 22V Research Group shall not be liable for any direct or indirect, incidental or consequential loss or damage (including loss of profits, revenue or goodwill) arising from any investment decisions based on information or research obtained from 22V Research Group.

Reproduction And Distribution Strictly Prohibited.

No user of this Report may reproduce, modify, copy, distribute, sell, resell, transmit, transfer, license, assign or publish the Report itself or any information contained therein. Notwithstanding the foregoing, clients with access to working models are permitted to alter or modify the information contained therein, provided that it is solely for such client’s own use. This Report is not intended to be available or distributed for any purpose that would be deemed unlawful or otherwise prohibited by any local, state, national or international laws or regulations or would otherwise subject the Company to registration or regulation of any kind within such jurisdiction.

Copyrights, Trademarks, Intellectual Property.

22V Research Group, and any logos or marks included in this Report are proprietary materials. The use of such terms and logos and marks without the express written consent of 22V Research Group is strictly prohibited. The copyright in the pages or in the screens of the Report, and in the information and material therein, is proprietary material owned by 22V Research Group unless otherwise indicated. The unauthorized use of any material on this Report may violate numerous statutes, regulations and laws, including, but not limited to, copyright, trademark, trade secret or patent laws.